P 56- SHORT-TERM RESPONSE OF P300 EVOKED POTENTIAL IN PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY TREATED WITH L-ORNITHINE, L-ASPARTATE

P 56- SHORT-TERM RESPONSE OF P300 EVOKED POTENTIAL IN PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY TREATED WITH L-ORNITHINE, L-ASPARTATE

Introduction and Objectives: The clinical alterations of Minimal Hepatic Encephalopathy (MHE) include subtle changes in cognitive processes detectable only with tests such as the Psychometric hepatic encephalopathy score (PHES) and critical blink rate (FCP) or P300 cognitive evoked potentials. After...

Full description

Bibliographic Details
Main Authors:	José Luis Pérez-Hernández, Christian Hinojosa-Segura, Diana Montemira-Orozco, Andrés Burak-Leipuner, Juana Zavala-Ramírez, Imram Cruz-Reyes, María Escobedo-Silva, Fátima Higuera-de la Tijera, Daniel Santana-Vargas
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Series:	Annals of Hepatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268123000595

Similar Items

Short-term response of p300 evoked potential in patients with minimal hepatic encephalopathy treated with l-ornithine, l-aspartate
by: CI Hinojosa-Segura, et al.
Published: (2022-12-01)

Efficacy and safety of intravenous L-ornithine L-aspartate in patients with grade III and IV hepatic encephalopathy
by: Gabriela Rangel-Zavala, et al.
Published: (2024-02-01)

Short-term efficacy and safety of l-ornithine l-aspartate therapy in patients with cirrhosis and minimal hepatic encephalopathy: a real-life cohort study
by: AB Moreno-Cobos, et al.
Published: (2022-12-01)

Critical analysis of studies evaluating the efficacy of infusion of L-ornithine L-aspartate in clinical hepatic encephalopathy in patients with liver failure
by: José Luis Pérez Hernández, et al.
Published: (2011-01-01)

Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy
by: Claudia Isabel Blanco Vela, et al.
Published: (2011-01-01)

Nitric oxide-mediated effects of L-ornithine-L-aspartate in acute toxic liver injury
by: Vitalij Datsko, et al.
Published: (2022-06-01)

Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease
by: Roger F. Butterworth, et al.
Published: (2019-03-01)

Changes in early visual perception in patients with minimal hepatic encephalopathy
by: D Montemira-Orozco, et al.
Published: (2022-12-01)

Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: A randomized controlled trial
by: Kapil Sharma, et al.
Published: (2014-01-01)

L-Ornithine-L-Aspartate and Intermittent Renal Replacement Therapy in Fulminant Hepatitis A
by: Nourhane Obeid, et al.
Published: (2023-03-01)

P- 91 CHANGES IN EARLY VISUAL PERCEPTION IN PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY
by: José Luis Pérez Hernández, et al.
Published: (2023-03-01)

Oral Intake of L-Ornithine-L-Aspartate Is Associated with Distinct Microbiome and Metabolome Changes in Cirrhosis
by: Angela Horvath, et al.
Published: (2022-02-01)

Efficacy of L-Ornithine L-Aspartate in Recovery of Patients Suffering from Acute Viral Hepatitis
by: Ebtihal Bilal, et al.
Published: (2023-06-01)

Impact of L-ornithine L-aspartate on non-alcoholic steatohepatitis-associated hyperammonemia and muscle alterations
by: Camille Pichon, et al.
Published: (2022-11-01)

Efek L-Ornithine L-Aspartate (Hepamerz ) terhadap Digit Symbol Test pada pasien Ensefalopati Hepatikum
by: , PRABOWO, Panji Aryo, et al.
Published: (2008)

L-Ornithine L-Aspartate Restores Mitochondrial Function and Modulates Intracellular Calcium Homeostasis in Parkinson’s Disease Models
by: Maria Josè Sisalli, et al.
Published: (2022-09-01)

Application of the Original L-Ornithine-L-Aspartate in Patients with Complex Cardiovascular Disease and Type 2 Diabetes Mellitus
by: V.Yu. Zharynova, et al.
Published: (2015-11-01)

Bipolar Membrane Electrodialysis for Direct Conversion of L-Ornithine Monohydrochloride to L-Ornithine
by: Jinfeng He, et al.
Published: (2023-08-01)

Auditory evoked potential P300 in adults: reference values
by: Dayane Domeneghini Didoné, et al.

Sarcopenia as a predictor of risk of minimal hepatic encephalopathy in patients with liver cirrhosis
by: O Morales Gutiérrez, et al.
Published: (2022-12-01)

Latência do potencial evocado auditivo P300 em idosos P300 auditory evoked potential latency in elderly
by: Maria José Santos Cóser, et al.
Published: (2010-06-01)

P-31 SHORT-TERM EFFICACY AND SAFETY OF LOLA THERAPY IN PATIENTS WITH CIRRHOSIS AND MINIMAL HEPATIC ENCEPHALOPATHY: A REAL-LIFE COHORT STUDY
by: Fátima Higuera-De La Tijera, et al.
Published: (2023-03-01)

Cognitive Evoked Potentials P300 And CNV In Patients' With Parkinson Disease
by: Iván Delgado Suárez, et al.
Published: (2019-05-01)

Cognitive evoked potentials P300 and CNV in patients' with Parkinson disease
by: Iván Delgado Suárez, et al.
Published: (2020-01-01)

Role of Brain Biomarkers S-100-Beta and Neuron-Specific Enolase for Detection and Follow-Up of Hepatic Encephalopathy in Cirrhosis before, during and after Treatment with L-Ornithine-L-Aspartate
by: Hendrik Strebel, et al.
Published: (2020-04-01)

Comparison of the Ornithine Carbamyltransferase with Aspartate Aminotransferase and Alanine Aminotransferase in patients with liver diseases
by: HR.Joshaghani, et al.
Published: (2002-09-01)

Recording visual evoked potentials and auditory evoked P300 at 9.4T static magnetic field.
by: Jorge Arrubla, et al.
Published: (2013-01-01)

the variability in P300 cognitive evoked potential amplitude in the auditory oddball paradigm
by: Biševac B., et al.
Published: (2015-01-01)

P062: A case of ornithine transcarbamylase deficiency
by: Suad Siuffi Campo, et al.
Published: (2024-01-01)

The study of cognitive evoked potentials (P 300) in boxers with repeated traumatic brain injury
by: Andriy Muravskiy, et al.
Published: (2015-09-01)

Investigation of P300 evoked by Stroop Color Word Task in children with emotional neglect
by: Yang Shichang, et al.
Published: (2022-02-01)

The P300 Auditory Evoked Potential in Cochlear Implant Users: A Scoping Review
by: Maria Stella Arantes do Amaral, et al.
Published: (2023-07-01)

Cognitive Evoked Potential Measurement, P300, in a group of healthy Colombian individuals
by: Natalia Gutiérrez Giraldo, et al.
Published: (2013-05-01)

Síndrome da apneia obstrutiva do sono e o potencial auditivo P300 Obstructive sleep apnea and P300 evoked auditory potential
by: Carlos Henrique Martins, et al.
Published: (2011-12-01)

P56
by: D. Meshalkina, et al.
Published: (2015-11-01)

A critical analysis of studies assessing L-ornithine-L-aspartate (LOLA) in hepatic encephalopathy treatment Uma análise crítica dos estudos de avaliação do L-ornitina-L-aspartato (LOLA) no tratamento da encefalopatia hepática
by: Patrícia Coelho de Soárez, et al.
Published: (2009-09-01)

Event-related modulation of alpha rhythm explains the auditory P300-evoked response in EEG
by: Alina Studenova, et al.
Published: (2023-12-01)

A change in the parameters of P300 evoked potentials in relation to the degree of exacerbation of pain syndrome
by: A P Rachin, et al.
Published: (2012-06-01)

Is there a change in P300 evoked potential after 6 months in cochlear implant users?
by: Maria Stella Arantes do Amaral, et al.
Published: (2022-11-01)

Use of the Stockwell Transform in the Detection of P300 Evoked Potentials with Low-Cost Brain Sensors
by: Alan F. Pérez-Vidal, et al.
Published: (2018-05-01)